I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her ...

JPMorgan analyst Chris Schott says Eli Lilly’s Q4 miss represents a buying opportunity as the company is positioned for strong growth in 2025. The company’s 2025 sales guidanc ...

A $20 million Lilly Endowment grant aims to make Gary and Michigan City gateways to the Indiana Dunes National Park as a part of a broader effort to improve Northwest Indiana's connection to its ...

Though he'll forever be known as the COVID governor, here are some other key moments from Holcomb's eight years.

Two newly published water studies from the state predict that supply will continue to outpace demand for the vital resource ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been ...

Ongoing developments at the LEAP Research and Innovation District in Boone County were among the most significant local tech stories of 2024. Progress continued this year on LEAP, which stands for ...

Eli Lilly and Co. CEO David Ricks—IBJ ... high of $972 and announcements about big new investments in Lebanon and Ireland. Lilly’s stock price has retreated since that high mark, but Lilly ...

To QB or not to QB? That was the question Eli Stowers asked himself as the 2023 college football season approached for New Mexico State. The question answered itself. The answer not to QB.

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...

Eli Lilly (LLY) closed at $795.67 in the latest trading session, marking a -0.08% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 1.1%. Elsewhere ...